Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Ivana, Dedinská"'
Autor:
Patrícia Kleinová, Matej Vnučák, Karol Graňák, Monika Beliančinová, Tímea Blichová, Ivana Dedinská
Publikováno v:
Reports, Vol 7, Iss 3, p 70 (2024)
Background: Prostate cancer is the most common malignancy in men. Secondary nephrotic syndrome, a feature of paraneoplastic syndrome, occurs in 11% of cases and is mainly caused by membranous glomerulopathy. The association between minimal change dis
Externí odkaz:
https://doaj.org/article/4e79a08b255d41f4b197ad8be99c2cde
Autor:
Karol Graňák, Matej Vnučák, Monika Beliančinová, Patrícia Kleinová, Tímea Blichová, Margaréta Pytliaková, Ivana Dedinská
Publikováno v:
Medicina, Vol 60, Iss 8, p 1210 (2024)
Background and Objectives: Post-transplant diabetes mellitus (PTDM) is a significant risk factor for the survival of graft recipients and occurs in 10–30% of patients after kidney transplant (KT). PTDM is associated with premature cardiovascular mo
Externí odkaz:
https://doaj.org/article/18a6dfe8a3f74d439e8b5ee2e6b19db3
Autor:
Monika Beliančinová, Patrícia Kleinová, Tímea Blichová, Matej Vnučák, Karol Graňák, Katarína Kajová Macháleková, Ivana Dedinská
Publikováno v:
Biomedicines, Vol 12, Iss 3, p 548 (2024)
Background: The diagnosis of graft rejection relies on the identification of donor-specific antibodies along with histological findings. Borderline changes are particularly challenging, representing non-rejection findings in up to 70% of cases. The a
Externí odkaz:
https://doaj.org/article/1fb3054ae75247fda27eb0237c41bccc
Autor:
Matej Vnučák, Karol Graňák, Monika Beliančinová, Miloš Jeseňák, Katarína Kajová Macháleková, Jakub Benko, Matej Samoš, Ivana Dedinská
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-4 (2022)
Abstract COVID-19 infection remains a threat to the health systems of many countries. Potential success in the fight against the COVID-19 pandemic is the vaccination of high-risk groups, including patients with end-stage kidney disease (ESKD) and aft
Externí odkaz:
https://doaj.org/article/f6033620c4254f91b9ddde40684a35be
Autor:
Karol Graňák, Matej Vnučák, Monika Beliančinová, Patrícia Kleinová, Margaréta Pytliaková, Marián Mokáň, Ivana Dedinská
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionAdipokines are largely involved in the regulation of immune system activity. While leptin is the main pro-inflammatory marker of adipose tissue, adiponectin is characterized by anti-inflammatory effects. The aim of our study was to determ
Externí odkaz:
https://doaj.org/article/32b2deb3ceca4ad3838c36d9767c25ec
Autor:
Ivana Dedinská, Petra Skálová, Karol Graňák, Matej Vnučák, Tatiana Baltesová, Zuzana Žilinská, Miloš Jeseňák
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: Kidney transplant recipients appear to be at higher risk for critical COVID-19. Our analysis aimed to identify the possible risk factors for a severe course of the COVID-19 disease and to determine the influence of selected human leukocyt
Externí odkaz:
https://doaj.org/article/ba59f5dfd4694ca3be73636877a56636
Autor:
Karol Graňák, Matej Vnučák, Monika Beliančinová, Patrícia Kleinová, Margaréta Pytliaková, Juraj Miklušica, Ivana Dedinská
Publikováno v:
Medicina, Vol 58, Iss 11, p 1656 (2022)
Background and Objectives: It has been confirmed that adiponectin/leptin (A/L) ratio correlates better with cardiometabolic risk factors than hormone levels alone. The aim of our study was to determine the risk of developing post-transplant diabetes
Externí odkaz:
https://doaj.org/article/de0bb7eb7dfa4d94948da2e85f13687c
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background Acute kidney injury (AKI) affects approximately 13% of patients undergoing major abdominal surgery, and is a common and important clinical sign of perioperative injury. The aim of our analysis was to identify risk factors for AKI
Externí odkaz:
https://doaj.org/article/14a2c3683ff046ec8ca90b656c45ec1a
Publikováno v:
Vnitřní lékařství. 69:41-46
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06e881d159fd8e7b23527e93a97309aa
https://doi.org/10.36290/vnl.2023.006
https://doi.org/10.36290/vnl.2023.006
Autor:
Mohammad Mirzakhani, Mehdi Shahbazi, Roghayeh Akbari, Ivana Dedinská, Eghlim Nemati, Mousa Mohammadnia-Afrouzi
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Soluble CD30 (sCD30) is considered to be a marker for the activated immune system in which T cells can damage the allograft. Some studies reported that post-transplant sCD30 can predict early acute rejection and can thereby be used as a biomarker to
Externí odkaz:
https://doaj.org/article/166f588a5f684cbbb237b0617c224ab3